|
|
|
|
Intensive Lipid Lowering Reduces Cardiovascular Events in High-Risk Patients: Reported at ACC
-- Intensive lipid lowering with atorvastatin significantly reduces the risk of peripheral artery disease (PAD) compared with standard simvastatin therapy for patients with no history of PAD, but not for those with PAD history.However, intensive atorvastatin...
|
|
|
Vertebroplasty Relieves Pain Better Than Conservative Treatment in Acute Vertebral Fractures: Presented at SIR
-- Vertebroplasty led to significant pain relief compared with conservative therapy for patients with acute vertebral compression fractures, according to results from a study presented here at the 35th Annual Scientific Meeting of the Society of Interventional...
|
|
|
Bioavailable Testosterone Is Protective Against Alzheimer's Disease in Elderly Chinese Men: Presented at ADI
-- Bioavailable testosterone (BT) is a strong factor in decreased risk for the development of Alzheimer's disease (AD) in healthy elderly Chinese men, according to study results reported here at the 25th Conference of Alzheimer's Disease International (ADI).
|
|
|
Study Assesses Complications Associated With Nasal Ventilation in Newborns
-- More than 10% of newborns who receive oxygenation and ventilation using nasal continuous positive airway pressure (CPAP) in the neonatal intensive care unit (NICU) may experience complications inside or outside the nose, according to a study published in the...
|
|
|
Antiseptic Cloths Can Reduce Transmission of Treatment-Resistant Bacteria in Trauma Centres
-- Bathing trauma patients daily using cloths containing the antiseptic chlorhexidine may be associated with a decreased rate of colonisation and infection by methicillin-resistant Staphylococcus aureus (MRSA) and other difficult-to-treat bacteria, according to...
|
|
|
FDA adds boxed warning to Plavix to advise of reduced effectiveness in some patients
In a notice posted to its website, the FDA said a boxed warning was added to sanofi-aventis and Bristol-Myers Squibb's Plavix (clopidogrel) to warn about reduced effectiveness in certain patients who metabolise the antiplatelet drug poorly.In these patients,...
|
|
|
Abbott's TriCor fails to reduce cardiovascular risk is patients with diabetes: study
Data from the ACCORD trial presented at the American College of Cardiology annual scientific meeting demonstrated that patients with type 2 diabetes taking Abbott's TriCor (fenofibrate) along with simvastatin failed to achieve a significant reduction in...
|
|
|
Novartis' Diovan, Starlix failed to prevent disease in high-risk patients
Research findings presented at the American College of Cardiology annual meeting showed that Novartis' hypertension drug Diovan (valsartan) and diabetes treatment Starlix (nateglinide) failed to reduce the risk of heart attacks and related disease in patients...
|
|
|
Oral contraceptives may reduce death rate from any cause: study
Data from a prospective cohort study published in the British Medical Journal showed that women who use oral contraceptives have a significantly lower rate of death from any cause, including heart disease and all cancers, compared with women who have never used...
|
|
|
Roche: Avastin misses goal of late-stage prostate cancer trial
Roche and Genentech announced that topline results from a Phase III trial showed that Avastin (bevacizumab) in combination with docetaxel did not meet the study's primary endpoint of extending overall survival compared to chemotherapy and prednisone alone in...
|
